Placental angiogenesis

Placental Bed Disorders: Basic Science and its Translation to Obstetrics

Volumn , Issue , 2010, Pages 52-62

  Depoix, Christophe L ^a   Taylor, Robert N ^b  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84894325414     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511750847.008     Document Type: Chapter

References (58)

1. Risau W. Vasculogenesis, angiogenesis and endothelial cell differentiation during embryonic development. In: Feinberg RN, Sheror GK, Auerbach R, eds. The development of the vascular system. Philadelphia: Krager; 1991: pp. 58-68.
2. Duc-Goiran P, Mignot T M, Bourgeois C, et al. Embryo- maternal interactions at the implantation site: a delicate equilibrium. Eur J Obstet Gynecol Reprod Biol 1999; 83(1): 85-100.
3. Genbacev O, Zhou Y, Ludlow J W, et al. Regulation of human placental development by oxygen tension. Science 1997; 277(5332): 1669-72.
4. Kaufmann P, Mayhew T M, Charnock-Jones D S. Aspects of human fetoplacental vasculogenesis and angiogenesis. II. Changes during normal pregnancy. Placenta 2004; 25 (2-3): 114-26.
5. Jones C J, Jauniaux E. Ultrastructure of the materno- embryonic interface in the first trimester of pregnancy. Micron 1995; 26(2): 145-173.
6. Benirschke K, Kaufmann P. Architecture of normal villous tree. In: Pathology of the human placenta, 4th ed. New York: Springer-Verlag; 2000; ch 7.
7. Ramsey E M, Martin C B Jr, Donner M W. Fetal and maternal placental circulations: simultaneous visualization in monkeys by radiography. Am J Obstet Gynecol 1967; 98(3): 419-23.
8. Schuhmann R A. Placentone structure of the human placenta. Bibl Anat 1982; 22: 46-57.
9. Seval Y, Korgun E T, Demir R. Hofbauer cells in early human placenta: possible implications in vasculogenesis and angiogenesis. Placenta 2007; 28(8-9): 841-5.
10. de Groot C J, Chao V A, Roberts J M, Taylor R N. Human endothelial cell morphology and autacoid expression. Am J Physiol 1995; 268(4 Pt 2): H1613-20.
11. Jauniaux E, Watson A L, Hempstock J, et al. Onset of maternal arterial blood flow and placental oxidative stress: a possible factor in human early pregnancy failure. Am J Pathol 2000; 157(6): 2111-22.
12. Jauniaux E, Watson A, Burton G. Evaluation of respiratory gases and acid-base gradients in human fetal fluids and uteroplacental tissue between 7 and 16 weeks’ gestation. Am J Obstet Gynecol 2001; 184(5): 998-1003.
13. Kadyrov M, Kingdom J C, Huppertz B. Divergent trophoblast invasion and apoptosis in placental bed spiral arteries from pregnancies complicated by maternal anemia and early-onset preeclampsia/intrauterine growth restriction. Am J Obstet Gynecol 2006; 194(2): 557-63.
14. Kurz H, Burri P H, Djonov V G. Angiogenesis and vascular remodeling by intussusception: from form to function. News Physiol Sci 2003; 18: 65-70.
15. Pijnenborg R, Vercruysse L, Hanssens M. The uterine spiral arteries in human pregnancy: facts and controversies. Placenta 2006; 27(9-10): 939-58.
16. Nanaev A, Chwalisz K, Frank H G et al. Physiological dilation of uteroplacental arteries in the guinea pig depends on nitric oxide synthase activity of extravillous trophoblast. Cell Tissue Res 1995; 282(3): 407-21.
17. Lyall F, Bulmer J N, Kelly H et al. Human trophoblast invasion and spiral artery transformation: the role of nitric oxide. Am J Pathol 1999; 154(4): 1105-14.
18. Roy H, Bhardwaj S, Yla-Herttuala S. Biology of vascular endothelial growth factors. FEBS Lett 2006; 580(12): 2879-87.
19. Yamazaki Y, Morita T. Molecular and functional diversity of vascular endothelial growth factors. Mol Divers 2006; 10(4): 515-27.
20. Sato Y, Kanno S, Oda N et al. Properties of two VEGF receptors, Flt-1 and KDR, in signal transduction. Ann N YAcad Sci 2000; 902: 201-5.
21. Fujisawa H, Kitsukawa T. Receptors for collapsin/semaphorins. Curr Opin Neurobiol 1998; 8(5): 587-92.
22. Soker S, Takashima S, Miao HQ et al. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform- specific receptor for vascular endothelial growth factor. Cell 1998; 92(6): 735-45.
23. Maglione D, Guerriero V, Viglietto G et al. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA 1991; 88(20): 9267-71.
24. Tayade C, Hilchie D, He H et al. Genetic deletion of placenta growth factor in mice alters uterine NK cells. J Immunol 2007; 178(7): 4267-75.
25. Carmeliet P, Moons L, Luttun A et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 2001; 7(5): 575-83.
26. Park J E, Chen H H, Winer J et al. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity bindingto Flt-1 but not to Flk-1/KDR. JBiolChem 1994; 269(41): 25646-54.
27. Athanassiades A, Lala P K. Role of placenta growth factor (PlGF) in human extravillous trophoblast proliferation, migration and invasiveness. Placenta 1998; 19(7): 465-73.
28. Takahashi T, Yamaguchi S, Chida K et al. A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells. EMBO J 2001; 20(11): 2768-78.
29. Shalaby F, Rossant J, Yamaguchi T P et al. Failure of blood-island formation and vasculogenesis in Flk-1- deficient mice. Nature 1995; 376(6535): 62-6.
30. Fong G H, Rossant J, Gertsenstein M et al. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 1995; 376(6535): 66-70.
31. Kendall RL, Thomas K A. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci USA 1993; 90(22): 10705-9.
32. Helske S, Vuorela P, Carpen O et al. Expression of vascular endothelial growth factor receptors 1, 2 and 3 in placentas from normal and complicated pregnancies. Mol Hum Reprod 2001; 7(2): 205-10.
33. Rajakumar A, Michael H M, Rajakumar P A et al. Extraplacental expression of vascular endothelial growth factor receptor-1 (Flt-1), and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women. Placenta 2005; 26(7): 563-73.
34. Ferrara N, Carver-Moore K, Chen H et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996; 380(6573): 439-42.
35. Kaluz S, Kaluzova M, Stanbridge E J. Regulation of gene expression by hypoxia: integration of the HIF- transduced hypoxic signal at the hypoxia-responsive element. Clin Chim Acta 2008; 395(1-2): 6-13.
36. Ahmed A, Dunk C, Ahmad S et al. Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PIGF) and soluble Flt-1 by oxygen: a review. Placenta 2000; 21 (Suppl A): S16-S24.
37. Munaut C, Lorquet S, Pequeux C et al. Hypoxia is responsible for soluble vascular endothelial growth factor receptor-1 (VEGFR-1) but not for soluble endoglin induction in villous trophoblast. Hum Reprod 2008; 23(6): 1407-15.
38. Nishimoto F, Sakata M, Minekawa R et al. Metal transcription factor-1 is involved in hypoxia-dependent regulation of placenta growth factor in trophoblast- derived cells. Endocrinology 2009; 150: 1801-8.
39. Hunter A, Aitkenhead M, Caldwell C et al. Serum levels of vascular endothelial growth factor in preeclamptic and normotensive pregnancy. Hypertension 2000; 36(6): 965-9.
40. Levine R J, Maynard S E, Qian C et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350(7): 672-83.
41. Taylor RN, Grimwood J, Taylor RS et al. Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies. Am J Obstet Gynecol 2003; 188 (1): 177-82.
42. Johns J, Jauniaux E. Placental haematomas in early pregnancy. Br JHosp Med (Lond) 2007; 68(1): 32-5.
43. Charnock-Jones D S. Soluble flt-1 and the angiopoietins in the development and regulation of placental vasculature. J Anat 2002; 200(6): 607-15.
44. Schiessl B, Innes B A, Bulmer J N et al. Localization of angiogenic growth factors and their receptors in the human placental bed throughout normal human pregnancy. Placenta 2009; 30(1): 79-87.
45. Zhang E G, Smith S K, Baker P N et al. The regulation and localization of angiopoietin-1, -2, and their receptor Tie2 in normal and pathologic human placentae. Mol Med 2001; 7(9): 624-35.
46. Gospodarowicz D. Purification of a fibroblast growth factor from bovine pituitary. J Biol Chem 1975; 250(7): 2515-20.
47. Shing Y, Folkman J, Sullivan R, et al. Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor. Science 1984; 223(4642): 1296-9.
48. Ribatti D, Conconi M T, Nussdorfer G G. Nonclassic endogenous novel regulators of angiogenesis. Pharmacol Rev 2007; 59(2): 185-205.
49. Ferriani R A, Ahmed A, Sharkey A et al. Colocalization of acidic and fibroblastic growth factor (FGF) in human placenta and the cellular effects of bFGF in trophoblast cell line JEG-3. Growth Factors 1994; 10(4): 259-68.
50. Murakami M, Simons M. Fibroblast growth factor regulation of neovascularization. Curr Opin Hematol 2008; 15(3): 215-20.
51. Rudge J S, Holash J, Hylton D et al. Inaugural article: VEGF Trap complex formation measures production rates of VEGF, providing a biomarker for predicting efficacious angiogenic blockade. Proc Natl Acad Sci USA 2007; 104(47): 18363-70.
52. Govinden R, Bhoola KD. Genealogy, expression, and cellular function of transforming growth factor-beta. Pharmacol Ther 2003; 98(2): 257-65.
53. Pepper M S. Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev 1997; 8(1): 21-43.
54. Bowen J M, Chamley L, Mitchell M D et al. Cytokines of the placenta and extra-placental membranes: biosynthesis, secretion and roles in establishment of pregnancy in women. Placenta 2002; 23(4): 239-56.
55. Jones RL, Stoikos C, Findlay J K et al. TGF-beta superfamily expression and actions in the endometrium and placenta. Reproduction 2006; 132(2): 217-32.
56. Bernabeu C, Conley B A, Vary C P. Novel biochemical pathways of endoglin in vascular cell physiology. J Cell Biochem 2007; 102(6): 1375-88.
57. Levine R J, Lam C, Qian C et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. NEngl J Med 2006; 355(10): 992-1005.
58. Luft F C. Soluble endoglin (sEng) joins the soluble fms- like tyrosine kinase (sFlt) receptor as a pre-eclampsia molecule. Nephrol Dial Transplant 2006; 21(11): 3052-4.